Skip to main content
Volume 2, No 4 - Fall 2009

Volume 2, No 4 - Fall 2009

Table of Contents

Creating the World’s Most Expensive Circumcision
[Rev Obstet Gynecol. 2009;2(4):209-210 doi:10.3909/riog0097]© 2009 MedReviews®, LLC
A Gnawing Pain Images in Ob-Gyn
[Rev Obstet Gynecol. 2009;2(4):211 doi: 10.3909/riog0087]© 2009 MedReviews®, LLC
Reducing Surgical Site Infections: A Review Treatment Review
Infection at or near surgical incisions within 30 days of an operative procedure contributes substantially to surgical morbidity and mortality each year. The prevention of surgical site infections encompasses meticulous operative technique, timely administration of appropriate preoperative antibiotics, and a variety of preventive measures aimed at neutralizing the threat of bacterial, viral, and fungal contamination posed by operative staff, the operating room environment, and the patient’s endogenous skin flora. It is the latter aspect of contamination, and specifically mechanical methods of prevention, on which this review focuses.[Rev Obstet Gynecol. 2009;2(4):212-221 doi: 10.3909/riog0084]© 2009 MedReviews®, LLC
The Risks of Not Breastfeeding for Mothers and Infants Mangement Review
Health outcomes in developed countries differ substantially for mothers and infants who formula feed compared with those who breastfeed. For infants, not being breastfed is associated with an increased incidence of infectious morbidity, as well as elevated risks of childhood obesity, type 1 and type 2 diabetes, leukemia, and sudden infant death syndrome. For mothers, failure to breastfeed is associated with an increased incidence of premenopausal breast cancer, ovarian cancer, retained gestational weight gain, type 2 diabetes, myocardial infarction, and the metabolic syndrome. Obstetricians are uniquely positioned to counsel mothers about the health impact of breastfeeding and to ensure that mothers and infants receive appropriate, evidence-based care, starting at birth.[Rev Obstet Gynecol. 2009;2(4):222-231 doi: 10.3909/riog0093]© 2009 MedReviews®, LLC
Polycystic Ovary Syndrome: A Major Unrecognized Cardiovascular Risk Factor in Women Diagnosis Update
The prevalence of polycystic ovary syndrome (PCOS) is estimated to be nearly 10% among reproductive-age women. PCOS may represent the largest underappreciated segment of the female population at risk of cardiovascular disease. Clinicians providing care to women of childbearing age must recognize the presenting clues, including irregular menses, hirsutism, alopecia, hyperandrogenemia, and obesity. The pathophysiology of PCOS is complex, involving the hypothalamus-pituitary-ovarian axis, ovarian theca cell hyperplasia, hyperinsulinemia, and a multitude of other cytokine- and adipocyte-driven factors. Cardiac risk factors associated with PCOS have public health implications and should drive early screening and intervention measures. There are no consensus guidelines regarding screening for cardiovascular disease in patients with PCOS. Fasting lipid profiles and glucose examinations should be performed regularly. Carotid intimal medial thickness examinations should begin at age 30 years, and coronary calcium screening should begin at age 45 years. Treatment of the associated cardiovascular risk factors, including insulin resistance, hypertension, and dyslipidemia, should be incorporated into the routine PCOS patient wellness care program.[Rev Obstet Gynecol. 2009;2(4):232-239 doi: 10.3909/riog0094]© 2009 MedReviews®, LLC
Cervical Cancer: A Preventable Death
Cervical cancer kills 260,000 women annually, and nearly 85% of these deaths occur in developing nations, where it is the leading cause of cancer deaths in women. Disparities of health and poverty play a large role in this high mortality rate. Whereas routine Papanicolaou and human papillomavirus (HPV) testing has dramatically reduced cervical cancer deaths in Western nations, without proper infrastructure, facilities, and medical training, the rates of cervical cancer in developing nations will remain high. Studies on HPV DNA testing and the low-technology method of “screen and treat” are promising. In addition, reducing the cost and increasing the availability of HPV vaccines in developing nations brings hope and promise to the next generation of women.[Rev Obstet Gynecol. 2009;2(4):240-244 doi: 10.3909/riog0100]© 2009 MedReviews®, LLC
Off-Label Use of Misoprostol and Oxytocin Pharmacology
[Rev Obstet Gynecol. 2009;2(4):245-246 doi 10.3909/riog0099a]© 2009 MedReviews®, LLC
Treating Chronic Pelvic Pain Chronic Pain
[Rev Obstet Gynecol. 2009;2(4):246 doi 10.3909/riog0099b]© 2009 MedReviews®, LLC
Pregnancy Rates After Oral Contraceptive Use Oral Contraceptives
[Rev Obstet Gynecol. 2009;2(4):246-247 doi 10.3909/riog0099c]© 2009 MedReviews®, LLC
Approaches to Treating Osteoporosis Osteoporosis
[Rev Obstet Gynecol. 2009;2(4):247 doi 10.3909/riog0099d]© 2009 MedReviews®, LLC
Snippets Miscellaneous
[Rev Obstet Gynecol. 2009;2(4):247-248 doi 10.3909/riog0099e]© 2009 MedReviews®, LLC
Kii® Advanced Fixation Access System, Applied Medical Resources Corporation Fall 2009 Product Reviews
[Rev Obstet Gynecol. 2009;2(4):249-250 doi: 10.3909/riog0095]© 2009 MedReviews®, LLC
TRS100SB Tissue Retrieval System, Anchor Products Company Fall 2009 Product Reviews
[Rev Obstet Gynecol. 2009;2(4):250-251 doi: 10.3909/riog0096]© 2009 MedReviews®, LLC